Suppr超能文献

桡动脉与隐静脉和右内乳动脉在冠状动脉旁路移植术中的应用比较。

Radial artery versus saphenous vein versus right internal thoracic artery for coronary artery bypass grafting.

机构信息

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.

Department of Medicine, Division of Cardiology, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA.

出版信息

Eur J Cardiothorac Surg. 2022 Jun 15;62(1). doi: 10.1093/ejcts/ezac345.

Abstract

OBJECTIVES

We used individual patient data from 4 of the largest contemporary coronary bypass surgery trials to evaluate differences in long-term outcomes when radial artery (RA), right internal thoracic artery (RITA) or saphenous vein graft (SVG) are used to complement the left internal thoracic artery-to-left anterior descending graft.

METHODS

Primary outcome was all-cause mortality. Secondary outcome was a composite of major adverse cardiac and cerebrovascular events (all-cause mortality, myocardial infarction and stroke). Propensity score matching and Cox regression were used to reduce the effect of treatment selection bias and confounders.

RESULTS

A total of 10 256 patients (1510 RITA; 1385 RA; 7361 SVG) were included. The matched population consisted of 1776 propensity score-matched triplets. The mean follow-up was 7.9 ± 0.1, 7.8 ± 0.1 and 7.8 ± 0.1 years in the RITA, RA and SVG cohorts respectively. All-cause mortality was significantly lower in the RA versus the SVG [hazard ratio (HR) 0.62, 95% confidence interval (CI): 0.51-0.76, P = 0.003] and the RITA group (HR 0.59, 95% CI 0.48-0.71, P = 0.001). Major adverse cardiac and cerebrovascular event rate was also lower in the RA group versus the SVG (HR 0.78, 95% CI 0.67-0.90, P = 0.04) and the RITA group (HR 0.75, 95% CI 0.65-0.86, P = 0.02). Results were consistent in the Cox-adjusted analysis and solid to hidden confounders.

CONCLUSIONS

In this pooled analysis of 4 large coronary bypass surgery trials, the use of the RA was associated with better clinical outcomes when compared to SVG and RITA.

摘要

目的

我们利用 4 项最大的当代冠状动脉旁路移植术试验的个体患者数据,评估当使用桡动脉(RA)、右内乳动脉(RITA)或隐静脉移植物(SVG)来补充左内乳动脉至前降支移植物时,长期结局的差异。

方法

主要结局为全因死亡率。次要结局为主要不良心脏和脑血管事件的复合结局(全因死亡率、心肌梗死和卒中等)。采用倾向评分匹配和 Cox 回归来降低治疗选择偏倚和混杂因素的影响。

结果

共纳入 10256 例患者(1510 例 RITA;1385 例 RA;7361 例 SVG)。匹配的队列包括 1776 例倾向评分匹配的三联体。RITA、RA 和 SVG 组的平均随访时间分别为 7.9±0.1、7.8±0.1 和 7.8±0.1 年。RA 组与 SVG 组(风险比 [HR] 0.62,95%置信区间 [CI]:0.51-0.76,P=0.003)和 RITA 组(HR 0.59,95% CI 0.48-0.71,P=0.001)的全因死亡率显著降低。RA 组的主要不良心脏和脑血管事件发生率也低于 SVG 组(HR 0.78,95% CI 0.67-0.90,P=0.04)和 RITA 组(HR 0.75,95% CI 0.65-0.86,P=0.02)。在 Cox 调整分析和对潜在混杂因素的稳健性检验中,结果一致。

结论

在这 4 项大型冠状动脉旁路移植术试验的汇总分析中,与 SVG 和 RITA 相比,RA 的使用与更好的临床结局相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验